Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combigan vs Latanoprost in Glaucoma or Ocular Hypertension
NCT00811564Phase 4Completed
- Sponsor
- Allergan
- Start
- Dec 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine tartrate + timolol maleate in Glaucoma, ocular hypertension, sponsored by Allergan. Started Dec 2008; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00811564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811564.